# Buprenorphine and Naloxone

NDC: 70518-3389
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20220316

FDA application: ANDA205601

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-3389"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-3389
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=072b2c2e-a564-4bb4-8954-9349a7923807